TCTR20210302003Enrolling By Invitation1 期
Efficacy and safety of fractional picosecond-domain laser (PSL) for atrophic traumatic and surgical scars : A randomized split-scar study
Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University0 个研究点目标入组 25 人开始时间: 2021年3月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1. Healthy male or female participants, aged 18-65.
- •2. Participants had s atrophic dramatic scar or atrophic surgical scar more than 2 cm. for more than 1 year in any position of the body.
- •3. Participants who are willing to join the project after receiving a detailed description of the project and signing a consent form for the study.
- •4. Participants can follow the testing method to follow up on treatment results throughout the study period and can report side effects that arise from the study immediately.
排除标准
- •1. Participant with a previous history of keloid scars.
- •2. Participants had a history of using systemic retinoids (acitretin, isotretinoin) within 6 months prior to the start of the study.
- •3.Participants have a history of treatment for atrophic scar such as topical vitamin A, topical drugs that exfoliate or exfoliate skin, microdermabrasion, and chemical peeling. Before, within 6 months prior to the start of research
- •4. Participants who are pregnant, breastfeeding, or planning to become pregnant.
- •5. Participants had a history of connective tissue disease.
- •6. Participants who took immunosuppressants (Immunosuppressive agents)
- •7. Participants with any type of diabetes mellitus.
- •8. Participants with diseases that make ulcers difficult to heal, such as sclerosis, peripheral arterial disease, etc.
- •9. Participant with infectious conditions in the treated area such as herpes, acne, cellulitis, etc.
- •10. Participants with a history of local anesthesia.
研究者
相似试验
招募中
4 期
Efficacy and Safety of Fractional 1064 nm Picosecond Laser for the Treatment of Mammoplasty Scar in Asians: A Prospective, Randomized Comparative StudyPatients with mammoplasty scar s on both sided of breastmammoplasty scar, picosecond laser, fractional 1064 nm picosecond laserTCTR20210730001Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand24
已完成
4 期
Clinical outcome of 1064-nm fractional picosecond laser for the treatment of post-mastectomy scar in transmen: A randomized controlled trial studyEfficacy and safety of 1064-nm fractional picosecond laser (FxPico) treatment for hypertrophic and atrophic post-mastectomy scars in transmen.Atrophic scar, Female-to-male transgender, Hypertrophic scar, Picosecond laser, Post-mastectomy scar, Transgender men, and Transmen.TCTR20230306002Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi hospital22
招募中
4 期
Efficacy and safety of fractional 1064-nm picosecond laser on skin qualityPatient with mild to moderate wrinklefractional 1064-nm picosecond laser,skin qualityTCTR20230516009lasermed co. ltd30
招募中
4 期
Efficacy and safety of fractional 1064-nm picosecond laser on skin qualityHealthy personfractional 1064-nm picosecond laser,skin qualityTCTR20230417008Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand30
招募中
2 期
Investigating the safety and efficacy of fractional microneedle Sophia device, in rejuvenating facial skiSkin ageing.IRCT20190210042676N26Parnian Gostar Radiometer Company21